Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy

KR Crews, AA Monte, R Huddart… - Clinical …, 2021 - Wiley Online Library
Opioids are mainly used to treat both acute and chronic pain. Several opioids are
metabolized to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone, and …

Trends in tramadol: pharmacology, metabolism, and misuse

K Miotto, AK Cho, MA Khalil, K Blanco… - Anesthesia & …, 2017 - journals.lww.com
Tramadol is a unique analgesic medication, available in variety of formulations, with both
monoaminergic reuptake inhibitory and opioid receptor agonist activity increasingly …

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update

KR Crews, A Gaedigk… - Clinical …, 2014 - Wiley Online Library
Codeine is bioactivated to morphine, a strong opioid agonist, by the hepatic cytochrome
P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine are governed by CYP2D6 …

Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II

SF Zhou - Clinical pharmacokinetics, 2009 - Springer
Part I of this article discussed the potential functional importance of genetic mutations and
alleles of the human cytochrome P450 2D6 (CYP2D6) gene. The impact of CYP2D6 …

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

M Ingelman-Sundberg, SC Sim, A Gomez… - Pharmacology & …, 2007 - Elsevier
The polymorphic nature of the cytochrome P450 (CYP) genes affects individual drug
response and adverse reactions to a great extent. This variation includes copy number …

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype

KR Crews, A Gaedigk… - Clinical …, 2012 - Wiley Online Library
Codeine is bioactivated to morphine, a strong opioid agonist, by the hepatic cytochrome
P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine as an analgesic are …

Review of opioid pharmacogenetics and considerations for pain management

A Owusu Obeng, I Hamadeh… - … : The Journal of Human …, 2017 - Wiley Online Library
Opioid analgesics are the standards of care for the treatment of moderate to severe
nociceptive pain, particularly in the setting of cancer and surgery. Their analgesic properties …

[HTML][HTML] CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial

DM Smith, KW Weitzel, AR Elsey, T Langaee… - Genetics in …, 2019 - Elsevier
Purpose CYP2D6 bioactivates codeine and tramadol, with intermediate and poor
metabolizers (IMs and PMs) expected to have impaired analgesia. This pragmatic proof-of …

Tolerance and withdrawal from prolonged opioid use in critically ill children

KJS Anand, DF Willson, J Berger, R Harrison… - …, 2010 - publications.aap.org
OBJECTIVE: After prolonged opioid exposure, children develop opioid-induced
hyperalgesia, tolerance, and withdrawal. Strategies for prevention and management should …

Opioids

B KuKanich, AJ Wiese - … and analgesia: The fifth edition of …, 2015 - Wiley Online Library
Opioids are the prototypical analgesics, antitussives, and antidiarrheal drug class. The
opioid receptor system or opioid effects have been identified in numerous animal species …